Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Jun 2024 for QuidelOrtho Corp.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Michael S. Iskra: trading record in brief
Michael S. Iskra (senior executive) discloses dealings in 2 companies, chiefly QuidelOrtho Corp and Ortho Clinical Diagnostics Holdings plc. The record holds 10 filings, for trades running from 21 May 2021 to 1 June 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 June 2024 came the latest disclosure, a share grant for €53k in QuidelOrtho Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael S. Iskra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,594 shares0Common StockSEC:0000950170-24-068686:0
4,925 shares0Common StockSEC:0000950170-24-039668:0
3,594 shares0Common StockSEC:0001209191-23-034579:0
15,825 shares0Common StockSEC:0001209191-23-022686:0
150,000 sharesOrdinary Shares, $0.00001 par valueSEC:0000899243-22-020385:0
150,000 shares0Ordinary SharesSEC:0001209191-21-035698:0
6 of 6 declarations
